Meng-Meng Wang Selected Research

Neoplasms (Cancer)

5/2024	Mitochondria-targeting metallodrugs for cancer therapy: perspectives from cell death modes.
4/2024	Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.
3/2024	Consolidating Organometallic Complex Ir-CA Empowers Mitochondria-Directed Chemotherapy against Resistant Cancer via Stemness and Metastasis Inhibition.
2/2024	Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy.
1/2023	Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels.
1/2023	Self-Assembly Mitochondria-Targeting Donor-Acceptor Type Theranostic Nanosphere Activates ROS Storm for Multimodal Cancer Therapy.
12/2022	[Mechanism of modified Liangge San in treatment of acute respiratory distress syndrome based on network pharmacology and experimental validation].
10/2022	The cyclometalated iridium (III) complex based on 9-Anthracenecarboxylic acid as a lysosomal-targeted anticancer agent.
1/2022	Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy.
1/2022	Mitochondria-targeted Pt(IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibition.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meng-Meng Wang Research Topics

Disease

25	Neoplasms (Cancer) 05/2024 - 04/2013
7	Neoplasm Metastasis (Metastasis) 03/2024 - 10/2018
5	Migraine Disorders (Migraine) 02/2024 - 06/2018
4	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2020
4	Inflammation (Inflammations) 01/2022 - 12/2015
3	Pain (Aches) 11/2023 - 06/2018
3	Ischemia 01/2023 - 01/2022
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 10/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 02/2022
2	Headache (Headaches) 02/2024 - 04/2023
2	Neuralgia (Stump Neuralgia) 11/2023 - 12/2020
2	Infarction (Infarctions) 01/2023 - 12/2015
2	Rupture 12/2022 - 01/2022
2	Abdominal Aortic Aneurysm 12/2022 - 01/2022
2	Acute Lung Injury 01/2022 - 11/2021
2	Sepsis (Septicemia) 11/2021 - 12/2017
2	Pneumonia (Pneumonitis) 01/2021 - 07/2011
2	Pulmonary Hypertension 02/2019 - 02/2017
1	Triple Negative Breast Neoplasms 04/2024
1	Hypoxia (Hypoxemia) 02/2024
1	Lung Neoplasms (Lung Cancer) 02/2024
1	Muscle Cramp (Cramp) 02/2024
1	ST Elevation Myocardial Infarction 12/2023
1	No-Reflow Phenomenon 12/2023
1	Visceral Pain 11/2023
1	Retinal Vein Occlusion 04/2023
1	Macular Edema 04/2023
1	Keloid 04/2023
1	Body Weight (Weight, Body) 04/2023
1	Alcoholic Fatty Liver 04/2023
1	Papillary Thyroid Cancer 01/2023
1	Carcinogenesis 01/2023
1	Myocardial Infarction 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Aortic Dissection 01/2023

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 04/2023 - 06/2011
6	Antineoplastic Agents (Antineoplastics)IBA 04/2024 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2015
5	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2020
4	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 01/2022
3	Matrix Metalloproteinases (MMPs)IBA 03/2024 - 10/2018
3	LigandsIBA 11/2023 - 12/2015
3	Nitroglycerin (Dynamite)FDA LinkGeneric 06/2022 - 06/2018
3	CalciumIBA 01/2020 - 12/2017
3	Messenger RNA (mRNA)IBA 01/2020 - 12/2015
2	PlatinumIBA 04/2024 - 01/2022
2	IridiumIBA 04/2024 - 11/2023
2	ProdrugsIBA 02/2024 - 01/2022
2	Cyclin D1IBA 11/2023 - 01/2023
2	MetalsIBA 11/2023 - 01/2023
2	Serotonin (5 Hydroxytryptamine)IBA 04/2023 - 07/2018
2	Interleukin-6 (Interleukin 6)IBA 04/2023 - 01/2021
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2022 - 01/2022
2	Opioid Receptors (Opioid Receptor)IBA 06/2022 - 12/2020
2	ZincIBA 01/2022 - 12/2021
2	Calcitonin Gene-Related PeptideIBA 07/2018 - 06/2018
2	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 12/2017 - 08/2015
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2017 - 08/2015
2	Polysaccharides (Glycans)IBA 02/2017 - 01/2015
1	RutheniumIBA 04/2024
1	Succinic Acid (Succinate)IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 03/2024
1	DNA (Deoxyribonucleic Acid)IBA 02/2024
1	CatalaseIBA 02/2024
1	NitrogenIBA 02/2024
1	Mechlorethamine (Nitrogen Mustard)FDA Link 02/2024
1	Glutathione (Reduced Glutathione)IBA 02/2024
1	A-Form DNA (A-DNA)IBA 02/2024
1	FlunarizineIBA 02/2024
1	ProstaglandinsIBA 02/2024
1	Dinoprostone (PGE2)FDA Link 02/2024
1	C-PeptideIBA 12/2023
1	Freund's AdjuvantIBA 11/2023
1	Formaldehyde (Formol)FDA Link 11/2023
1	Analgesics (Analgesic Drugs)IBA 11/2023
1	pterostilbeneIBA 11/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2023
1	Ranibizumab (Lucentis)FDA Link 04/2023
1	KH902 fusion proteinIBA 04/2023
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2023
1	Hormones (Hormone)IBA 04/2023
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 04/2023
1	NLR ProteinsIBA 04/2023
1	LipidsIBA 04/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	matrigelIBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2022

Therapy/Procedure

11	Therapeutics 05/2024 - 10/2018
3	Drug Therapy (Chemotherapy) 03/2024 - 01/2022
2	Aftercare (After-Treatment) 02/2024 - 04/2023
2	Precision Medicine 01/2023 - 01/2022
2	Subcutaneous Injections 06/2022 - 07/2018
2	Percutaneous Collagen Induction 07/2018 - 06/2018
1	Bloodletting 04/2023
1	Radiotherapy 04/2023
1	Injections 01/2023
1	Ligation 01/2023
1	Photochemotherapy (Photodynamic Therapy) 01/2023
1	Nanospheres 01/2023